BoNT-A Injections for Pediatric Spasticity: Optimizing Information Sharing and Consent for our Families and Practices-Session Presentation

Video Transcription

Video Summary

In this video, Drs. Ramsey and Wright discuss the use of botulinum toxin type A injections for pediatric spasticity. They cover topics such as FDA indications and dosing trends, labeling and warnings, pediatric litigation cases, elements of informed consent, and implementation of quality standards. They emphasize the importance of optimizing information sharing and consent for families and practitioners. They also provide insights into the risks associated with botulinum toxin injections and the need for careful dosing and monitoring of adverse events. They recommend a consistent and comprehensive consent process that includes verbal and written information about potential risks and benefits. The presenters also touch on the challenges of multidisciplinary care and the need for coordination and communication among providers. Overall, the video provides valuable information for practitioners involved in pediatric spasticity management and highlights the importance of patient education and safety in the use of botulinum toxin type A injections.

Keywords

botulinum toxin type A injections

pediatric spasticity

FDA indications

dosing trends

labeling and warnings

informed consent

adverse events

risks

consent process

patient education